Literature DB >> 7082398

The role of cell surface proteins in platelet stimulation by monosodium urate crystals.

B C Jaques, M H Ginsberg.   

Abstract

To test whether urate crystal-membrane protein interactions mediate platelet stimulation, platelet membrane proteins were radiolabeled by lactoperoxidase, extracted with 1% Triton X-100, and incubated with urate crystals. The crystal-associated and supernate fractions were isolated and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and by 2-dimensional isoelectric focusing followed by SDS-PAGE. Four of the lactoperoxidase-radiolabeled polypeptides that associated with urate crystals had reduced molecular weights and pIs of Mr = 105,000, pI 4.9; Mr = 123,000, pI = 4.9; Mr = 123,000, pI = 5.3; and Mr = 132,000, pI = 4.8-6.3, respectively. These proteins were characterized with regard to their labeling intensities, apparent isoelectric points, apparent molecular weights (reduced and nonreduced), lectin-binding properties, carbohydrate- and protein-staining characteristic, and presence or absence in Glanzmann's thrombasthenia. They have been identified as derived from glycoproteins Ib, IIb, and III (Phillips-Agin nomenclature) and an unidentified membrane protein. To test whether removal of these proteins would result in a diminution of platelet response to urate, intact platelets were digested with chymotrypsin, resulting in cleavage of more than 80% of these proteins and a 5-fold reduction in secretory responsiveness to urate crystals. Response to a second platelet stimulus, collagen, was unaffected, indicating an intact secretory mechanism. In addition, when platelets were preincubated with F(ab')2 fragments of an antibody directed against these proteins, platelet secretory response to urate was inhibited by 50%, whereas the responses to collagen and thrombin were unaffected. Thus, membrane proteins appear to mediate platelet stimulation by urate crystals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082398     DOI: 10.1002/art.1780250504

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

2.  Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.

Authors:  M H Ginsberg; A Lightsey; T J Kunicki; A Kaufmann; G Marguerie; E F Plow
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function.

Authors:  J C Loftus; E F Plow; A L Frelinger; S E D'Souza; D Dixon; J Lacy; J Sorge; M H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.

Authors:  Chun-Jen Chen; Yan Shi; Arron Hearn; Kate Fitzgerald; Douglas Golenbock; George Reed; Shizuo Akira; Kenneth L Rock
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 5.  Crystals, inflammation, and osteoarthritis.

Authors:  Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 6.  Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.

Authors:  George Nuki
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

7.  Impact of chronic diuretic treatment on glucose homeostasis.

Authors:  Silvio Buscemi; Antonio Nicolucci; Giuseppe Lucisano; Fabio Galvano; Giuseppe Grosso; Fatima M Massenti; Emanuele Amodio; Alice Bonura; Delia Sprini; Giovam B Rini
Journal:  Diabetol Metab Syndr       Date:  2013-12-13       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.